Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
Conditions
- Chronic Obstructive Pulmonary Disease, COPD
- Low Peak Inspiratory Flow Rate (PIFR)
Interventions
- DRUG: Revefenacin
- COMBINATION_PRODUCT: Spiriva Handihaler®
- DRUG: Placebo for Revefenacin
- DRUG: Placebo for Spiriva Handihaler®
Sponsor
Mylan Inc.
Collaborators